Back

Urocortin-2 as a novel biomarker of clinical deterioration in HFpEF: a prospective cohort study

11 May 2024 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - diagnostic methods 3 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Miss Ines Vasconcelos

Faculty of Medicine University of Porto, Porto (Portugal)

7 More presentations in this session

Presentation thumbnail
Usefulness of remote monitoring with the TRIAGE-HF score for the follow-up of patients with heart failure
Doctor D. Enriquez Vazquez (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Multi-frequency bioimpedance analysis in detecting fluid shifts in heart failure patients.
Doctor M. Winiarczyk (Cracow, PL)
Abstract Slides Video
Presentation thumbnail
Phase analysis of single-photon emission computerized tomography myocardial perfusion imaging (SPECT-MPI): closer to the root of left bundle branch block cardiomyopathy?
Ms C. Marques (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Point-of-care uLtrasound cAN make the difference in patients with Heart Failure at primary care - PLAN-HF
Doctor J. Dos Santos (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Development and clinical validation of an artificial intelligence-based decision support system for predicting risk, diagnosis, and progression of heart failure (STRATIFYHF): a study protocol
Professor D. Jakovljevic (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - diagnostic methods 3

The Event

Event poster

Heart Failure 2024

11 May 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Albuminuria is associated with progression of diastolic dysfunction in patients at risk for cardiovascular disease
thumbnail
Congress Presentation
Endothelial markers in type 2 diabetic patients with acute decompensated heart failure: a pilot study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources